<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-marinedrugs-18-00228">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tomura</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Nakamura</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Deguchi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Chida</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Ohno</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kodama</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Hayashi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Suzuki</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Marumo</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy</article-title>
  <source>Thromb. Res.</source>
  <year>1990</year>
  <volume>58</volume>
  <fpage>413</fpage>
  <lpage>419</lpage>
  <pub-id pub-id-type="doi">10.1016/0049-3848(90)90212-U</pub-id>
  <pub-id pub-id-type="pmid">2162087</pub-id>
 </element-citation>
</ref>
